Treosulfan Injection 5 gm/vial contains Treosulfan, an alkylating chemotherapeutic agent used in the treatment of certain cancers, including ovarian cancer, malignant lymphomas, and as part of conditioning regimens prior to hematopoietic stem cell transplantation. Treosulfan works by interfering with DNA replication and cell division in rapidly proliferating cancer cells, ultimately leading to cell death.
This injectable formulation is designed for intravenous administration, allowing rapid systemic delivery and effective treatment of malignancies. Treosulfan has both cytotoxic and myeloablative properties, making it valuable in oncology for both cancer therapy and preparative regimens before bone marrow or stem cell transplantation.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Potent Anticancer Activity: Targets rapidly dividing cancer cells to inhibit tumor growth.
Stem Cell Conditioning: Effective as part of pre-transplant regimens for bone marrow or stem cell transplantation.
Versatile Use: Applicable in ovarian cancer, malignant lymphomas, and other hematologic malignancies.
Controlled Administration: Intravenous delivery ensures optimal bioavailability and precise dosing.
Treosulfan is a bifunctional alkylating agent. It forms cross-links between DNA strands, disrupting DNA replication and transcription. This action prevents cell division and induces apoptosis (programmed cell death) in rapidly proliferating cancer cells. Additionally, its myeloablative effects prepare the bone marrow for stem cell transplantation by clearing existing hematopoietic cells.
Treosulfan Injection 5 gm/vial is indicated for:
Treatment of ovarian carcinoma
Management of malignant lymphomas and other hematologic malignancies
Conditioning regimen before hematopoietic stem cell transplantation
Other cancers as determined by an oncologist
Administered intravenously under the supervision of a qualified healthcare professional.
Dosage and duration are determined based on the patient’s body surface area, type of malignancy, and treatment protocol.
Prehydration and monitoring of renal and hepatic function are recommended to reduce toxicity.
Use appropriate protective measures when handling the drug due to its cytotoxic nature.
Use only under specialist supervision in oncology centers.
Monitor blood counts regularly to detect bone marrow suppression.
Adjust doses in patients with impaired kidney or liver function.
Avoid exposure to pregnant women and individuals handling the drug without protective equipment.
Inform your doctor about any previous treatments, allergies, or medical conditions.
Common side effects may include:
Nausea, vomiting, or diarrhea
Fatigue and weakness
Bone marrow suppression, leading to reduced blood cell counts
Hair thinning or loss
Infection due to immunosuppression
Seek immediate medical attention if severe infections, bleeding, or allergic reactions occur.
Store in a cool, dry place below 25°C, protected from light. Keep out of reach of children. Use reconstituted solutions as per manufacturer’s instructions.
Login Or Registerto submit your questions to seller
No none asked to seller yet